Mcl-1 as a “barrier” in cancer treatment: Can we target it now?-Reference-Cited by-同舟云学术

Mcl-1 as a “barrier” in cancer treatment: Can we target it now?

Published:2020 Issue: Volume: Page:23-55
ISSN:1937-6448
Container-title:Cell Death Regulation in Health and Disease - Part A
language:
Short-container-title:

Author:

Pervushin Nikolay V.,Senichkin Viacheslav V.,Zhivotovsky Boris,Kopeina Gelina S.

Publisher

Elsevier

Reference150 articles.

1. Mcl-1 is a potential therapeutic target in multiple types of cancer;Akgul;Cell. Mol. Life Sci.,2009

2. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA;Albershardt;J. Biol. Chem.,2011

3. Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma;Algarín;Haematologica,2019

4. Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage;Arbour;J. Neurosci.,2008

5. A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia;Arellano;Clin. Lymphoma Myeloma Leuk.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BH3-mimetics or DNA-damaging agents in combination with RG7388 overcome p53 mutation-induced resistance to MDM2 inhibition;Apoptosis;2024-09-02

2. Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1H-indole-1-yl Moiety Binding to the P1–P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells;Journal of Medicinal Chemistry;2024-08-09

3. Bcl-2 dependent modulation of Hippo pathway in cancer cells;Cell Communication and Signaling;2024-05-16

4. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions;Journal of Medicinal Chemistry;2024-04-10

5. Bio-orthogonally Activatable Fluorescent Probe for Specific Imaging of Myeloid Cell Leukemia 1 Protein;Analytical Chemistry;2023-12-11